Global Dermatological Drugs Market 2014-2018

Global Dermatological Drugs Market 2014-2018

Category : Pharmaceuticals
Published On : March  2014
Pages : 68

------------ Or -------------

TechNavio's analysts forecast the Global Dermatological Drugs market to grow at a CAGR of 4.29 percent over the period 2013-2018. One of the key factors contributing to this market’s growth is an increase in the aging population worldwide. The Global Dermatological Drugs market has also been witnessing a spurt in the use of biologics. However, the risk of adverse side effects associated with dermatological drugs could pose a challenge to the growth of this market. 
TechNavio's report, the Global Dermatological Drugs Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers Americas, EMEA and APAC regions; it also covers the Global Dermatological Drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors dominating this space include AbbVie Inc., Galderma S.A., Johnson & Johnson Ltd., Novartis AG, Stiefel Laboratories Inc., and Valeant Pharmaceuticals International Inc.
Other vendors mentioned in the report are Actavis plc, Allergan Inc., Almirall SA, Amgen Inc., Astellas Pharma Inc., AstraZeneca plc, Bayer AG, Bristol Myers Squibb Co., Celgene Corp., Eisai Co. Ltd., Eli Lilly and Co., Genentech Inc., Incyte Corp., Isotechnika Inc., LEO Pharma A/S, Merck & Co. Inc., Mylan Pharmaceuticals Inc., Pfizer Inc., and UCB SA.
Key questions answered in this report: 
What will the market size and growth rate be in 2018?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by key vendors?
What are the strengths and weaknesses of each of these key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details provided within the report.

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

03.1 Market Overview

03.2 Product Offerings

04. Market Research Methodology

04.1 Market Research Process

04.2 Research Methodology

05. Introduction

06. Market Landscape

06.1 Market Overview

06.2 Market Size and Forecast

06.3 Global Psoriasis Drugs Market

06.3.1 Market Size and Forecast

06.4 Global Acne Drugs Market

06.4.1 Market Size and Forecast

06.5 Global Dermatitis Drugs Market

06.5.1 Market Size and Forecast

06.6 Five Forces Analysis

07. Market Segmentation by Type

08. Geographical Segmentation

09. Buying Criteria

10. Rate of Incidence and Prevalence

Global Incidence and Prevalence of Psoriasis

Global Incidence and Prevalence of Acne

Global Incidence and Prevalence of Dermatitis

11. Market Growth Drivers

12. Drivers and their Impact

13. Market Challenges

14. Impact of Drivers and Challenges

15. Market Trends

16. Trends and their Impact

17. Vendor Landscape

17.1 Competitive Scenario

17.1.1 Key News

17.1.2 Mergers and Acquisitions

17.2 Market Analysis 2013

17.3 Other Prominent Vendors

18. Key Vendor Analysis

18.1 Abbvie Inc.

18.1.1 Business Overview

18.1.2 Key Information

18.1.3 SWOT Analysis

18.2 Galderma S.A.

18.2.1 Business Overview

18.2.2 Key Information

18.2.3 SWOT Analysis

18.3 Johnson & Johnson Ltd.

18.3.1 Business Overview

18.3.2 Business Segmentation

18.3.3 Key Information

18.3.4 SWOT Analysis

18.4 Novartis International AG

18.4.1 Business Overview

18.4.2 Business Segmentation

18.4.3 Key Information

18.4.4 SWOT Analysis

18.5 Stiefel Laboratories Inc.

18.5.1 Business Overview

18.5.2 Key Information

18.5.3 SWOT Analysis

18.6 Valeant Pharmaceuticals International Inc.

18.6.1 Business Overview

18.6.2 Business Segmentation

18.6.3 Key Information

18.6.4 SWOT Analysis

19. Other Reports in this Series

List of Exhibits

Exhibit 1: Market Research Methodology

Exhibit 2: Global Dermatological Drugs Market 2013-2018 (US$ billion)

Exhibit 3: Global Psoriasis Drugs Market 2013-2018 (US$ billion)

Exhibit 4: Global Acne Drugs Market 2013-2018 (US$ billion)

Exhibit 5: Global Dermatitis Drugs Market 2013-2018 (US$ billion)

Exhibit 6: Global Dermatological Drugs Market by Segmentation (revenue)

Exhibit 7: Global Dermatological Drugs Market by Segmentation (percentage)

Exhibit 8: Comparison of YOY Growth Rates among various Market Segments in Global Dermatological Drugs Market

Exhibit 9: Global Dermatological Drugs Market Segmentation by Types

Exhibit 10: Global Dermatological Drugs Market by Type 2013 (in percent)

Exhibit 11: Global Dermatological Drugs Market by Geographical Segmentation 2013

Exhibit 12: Business Segmentation of Johnson & Johnson Ltd.

Exhibit 13: Business Segmentation of Novartis AG

Exhibit 14: Business Segmentation of Valeant Pharmaceuticals International Inc.

Enquiry Before Buy